Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Biomerica, Inc. (NasdaqSC:BMRA)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider
Location
1533 Monrovia Avenue
Newport Beach, CA 92663
Phone: (949) 645-2111
Fax: (949) 722-6674
Email: info@biomerica.com
Employees (last reported count): 89
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 38%
·Over the last 6 months:
 · 4 insider buys; 157.0K shares (9.3% of insider shares)
·Institutional: 1% (1% of float)
(4 institutions)
·Net Inst. Selling: 35.0K shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Biomerica, Inc. is primarily engaged in the following activities: the development, manufacture and marketing of medical diagnostic kits; the design, manufacture and distribution of various orthodontic products; the performance of specialized diagnostic testing services; and the development of wireless handheld point-of-care systems for physicians. The Company conducts these businesses through three subsidiaries, Lancer Orthodontics, Inc., Allergy Immuno Technologies, Inc., and ReadyScript, Inc. Both Lancer and AIT are majority-controlled subsidiaries, while ReadyScript is a wholly owned subsidiary of Biomerica. The Company focuses in two separate areas, its diagnostic business and its proposed point-of-care wireless handheld technology solutions. The Company also continues to develop products for the diagnostics business.
More from Market Guide: Expanded Business Description

Financial Summary
Biomerica, Inc. develops, manufactures and sells medical diagnostic products designed to detect certain medical conditions and diseases in the areas of certain cancers, heart attack, fertility gastritis and ulcers, diabetes and candida. For the nine months ended 2/28/01, net sales rose 16% to $6.5 million. Net loss decreased 21% to $2 million. Results reflect increased sales from the EZ Detect product, along with decreased S/G/A expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Zackary Irani, 34
Chairman, Pres, CEO
$118K$24K
Janet Moore, 49
Sec., Treasurer, Controller, Interim CFO, Director
--  --  
Jagdish Sandhu, 49
Chief Operating Officer of the Diagnostic
--  --  
Dollar amounts are as of 31-May-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:BMRAAs of 31-Aug-2001
Price and Volume
52-Week Low
on 28-Dec-2000
$0.313
Recent Price$0.64 
52-Week High
on 7-Sep-2000
$1.844
Beta0.47 
Daily Volume (3-month avg)4,818 
Daily Volume (10-day avg)2,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-55.5%
52-Week Change
relative to S&P500
-40.3%
Share-Related Items
Market Capitalization$3.10M
Shares Outstanding4.85M
Float3.00M
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 2 on 14-Nov-1994
Per-Share Data
Book Value (mrq)$0.42 
Earnings (ttm)-$0.72 
Earnings (mrq)-$0.11 
Sales (ttm)$1.90 
Cash (mrq)$0.06 
Valuation Ratios
Price/Book (mrq)1.51 
Price/EarningsN/A 
Price/Sales (ttm)0.34 
Income Statements
Sales (ttm)$8.96M
EBITDA (ttm)-$3.18M
Income available to common (ttm)-$3.35M
Profitability
Profit Margin (ttm)-37.4%
Operating Margin (ttm)-37.8%
Fiscal Year
Fiscal Year EndsMay 31
Most recent quarter28-Feb-2001
Management Effectiveness
Return on Assets (ttm)-49.77%
Return on Equity (ttm)-129.01%
Financial Strength
Current Ratio (mrq)2.58 
Debt/Equity (mrq)0.13 
Total Cash (mrq)$289.0K
Short Interest
As of 8-Aug-2001
Shares Short9,000 
Percent of Float0.3%
Shares Short
(Prior Month)
7,000 
Short Ratio2.25 
Daily Volume4,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 28-Feb-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.